DrugPatentWatch Database Preview
La Jolla Pharma Company Profile
What is the competitive landscape for LA JOLLA PHARMA, and when can generic versions of LA JOLLA PHARMA drugs launch?
LA JOLLA PHARMA has one approved drug.
There are three US patents protecting LA JOLLA PHARMA drugs.
There are ten patent family members on LA JOLLA PHARMA drugs in ten countries.
Summary for La Jolla Pharma
| International Patents: | 10 |
| US Patents: | 3 |
| Tradenames: | 1 |
| Ingredients: | 1 |
| NDAs: | 1 |
Drugs and US Patents for La Jolla Pharma
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | RX | Yes | Yes | 9,867,863 | ➤ Sign Up | ➤ Sign Up | ||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-001 | Dec 21, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | |||||
| La Jolla Pharma | GIAPREZA | angiotensin ii acetate | SOLUTION;INTRAVENOUS | 209360-002 | Dec 21, 2017 | RX | Yes | Yes | 9,867,863 | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
International Patents for La Jolla Pharma Drugs
| Country | Document Number | Estimated Expiration |
|---|---|---|
| Mexico | 2016008108 | ➤ Sign Up |
| China | 106061493 | ➤ Sign Up |
| Eurasian Patent Organization | 201691258 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
